Pages that link to "Q31461224"

The following pages link to Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor (Q31461224):

Displaying 44 items.

• Gamma-hydroxybutyrate reduces mitogen-activated protein kinase phosphorylation via GABA B receptor activation in mouse frontal cortex and hippocampus (Q28202154) (← links)
• Synthesis and catabolism of gamma-hydroxybutyrate in SH-SY5Y human neuroblastoma cells: role of the aldo-keto reductase AKR7A2 (Q28307550) (← links)
• Succinic Semialdehyde Dehydrogenase: Biochemical–Molecular–Clinical Disease Mechanisms, Redox Regulation, and Functional Significance (Q28743137) (← links)
• Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (Gamma-Hydroxybutyric aciduria) (Q30881193) (← links)
• Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review. (Q33963037) (← links)
• An overview of gamma‐hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results (Q34168958) (← links)
• Sodium oxybate for the treatment of fibromyalgia (Q34193082) (← links)
• The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol (Q34285013) (← links)
• A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor. (Q34360139) (← links)
• Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism (Q35146643) (← links)
• The aldo-keto reductases (AKRs): Overview (Q35305934) (← links)
• GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome (Q35710620) (← links)
• Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships (Q36020907) (← links)
• Gamma hydroxy butyrate abuse and dependency (Q36116159) (← links)
• Gamma-hydroxybutyrate--a drug of abuse (Q36566720) (← links)
• gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness (Q36670850) (← links)
• Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects (Q36806659) (← links)
• Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid (Q36952136) (← links)
• Circadian distribution of generalized tonic-clonic seizures associated with murine succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. (Q36953244) (← links)
• Fibromyalgia syndrome: approach to management. (Q37103601) (← links)
• Polysomnographic abnormalities in succinic semialdehyde dehydrogenase (SSADH) deficiency (Q37449671) (← links)
• Reconsidering GHB: orphan drug or new model antidepressant? (Q37934335) (← links)
• Mechanisms for the Specific Properties of γ-Hydroxybutyrate in Brain (Q38688873) (← links)
• The role of aldehyde reductase AKR1A1 in the metabolism of gamma-hydroxybutyrate in 1321N1 human astrocytoma cells (Q39601249) (← links)
• Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs (Q41462770) (← links)
• Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice (Q41840617) (← links)
• Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease (Q43764355) (← links)
• A unique mouse model for succinic semialdehyde dehydrogenase deficiency with implications for gamma hydroxybutyrate intoxication (Q43979774) (← links)
• Clinical spectrum of succinic semialdehyde dehydrogenase deficiency (Q44438573) (← links)
• Quantitative autoradiographic analysis of the new radioligand [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid ([(3)H]NCS-382) at gamma-hydroxybutyric acid (GHB) binding sites in rat brain (Q44506341) (← links)
• Gamma-hydroxybutyric acid (GHB) measurement by GC-MS in blood, urine and gastric contents, following an acute intoxication in Belgium (Q44597346) (← links)
• Effects of γ-Hydroxybutyrate (GHB) on Schedule-Controlled Responding in Rats: Role of GHB and GABAB Receptors (Q44625332) (← links)
• Presynaptic modulation of spontaneous inhibitory postsynaptic currents by gamma-hydroxybutyrate in the substantia nigra pars compacta (Q44645830) (← links)
• Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system (Q44743799) (← links)
• Gamma-hydroxybutyric acid, unlike gamma-aminobutyric acid, does not stimulate Gi/Go proteins in rat brain membranes (Q44746109) (← links)
• The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family (Q44826656) (← links)
• Infantile spasms and Down syndrome: a new animal model (Q46134974) (← links)
• Succinate semialdehyde dehydrogenase deficiency does not down-regulate gamma-hydroxybutyric acid binding sites in the mouse brain (Q46889883) (← links)
• Neuronal oscillations and synchronicity associated with gamma-hydroxybutyrate during resting-state in healthy male volunteers (Q47739628) (← links)
• Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans (Q48352347) (← links)
• Immunohistochemical localization of a GHB receptor-like protein isolated from rat brain. (Q48460414) (← links)
• A novel ALDH5A1 mutation is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability in an Iranian family. (Q52883258) (← links)
• γ-Hydroxybutyrate does not mediate glucose inhibition of glucagon secretion (Q90198873) (← links)
• Prohedonic properties of gamma-hydroxybutyrate are associated with changes in limbic resting-state functional connectivity (Q93063954) (← links)